Abstract:Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) are related neurodegenerative diseases that belong to a common disease spectrum based on overlapping clinical, pathological and genetic evidence. Early pathological changes to the morphology and synapses of affected neuron populations in ALS/FTD suggest a common underlying mechanism of disease that requires further investigation. Fused in sarcoma (FUS) is a DNA/RNA-binding protein with known genetic and pathological links to ALS/FTD. Expression of ALS-linked FUS mutants in mice causes cognitive and motor defects, which correlate with loss of motor neuron dendritic branching and synapses, in addition to other pathological features of ALS/FTD. The role of ALS-linked FUS mutants in causing ALS/FTD-associated disease phenotypes is well established, but there are significant gaps in our understanding of the cell-autonomous role of FUS in promoting structural changes to motor neurons, and how these changes relate to disease progression. Here we generated a neuron-specific FUS-transgenic mouse model expressing the ALS-linked human FUSR521G variant, hFUSR521G/Syn1, to investigate the cell-autonomous role of FUSR521G in causing loss of dendritic branching and synapses of motor neurons, and to understand how these changes relate to ALS-associated phenotypes. Longitudinal analysis of mice revealed that cognitive impairments in juvenile hFUSR521G/Syn1 mice coincide with reduced dendritic branching of cortical motor neurons in the absence of motor impairments or changes in the neuromorphology of spinal motor neurons. Motor impairments and dendritic attrition of spinal motor neurons developed later in aged hFUSR521G/Syn1 mice, along with FUS cytoplasmic mislocalisation, mitochondrial abnormalities and glial activation. Neuroinflammation promotes neuronal dysfunction and drives disease progression in ALS/FTD. The therapeutic effects of inhibiting the pro-inflammatory nuclear factor kappa B (NF-κB) pathway with an analog of Withaferin A, IMS-088, were assessed in symptomatic hFUSR521G/Syn1 mice and were found to improve cognitive and motor function, increase dendritic branches and synapses of motor neurons, and attenuate other ALS/FTD-associated pathological features. Treatment of primary cortical neurons expressing FUSR521G with IMS-088 promoted the restoration of dendritic mitochondrial numbers and mitochondrial activity to wild-type levels, suggesting that inhibition of NF-κB permits the restoration of mitochondrial stasis in our models. Collectively, this work demonstrates that FUSR521G has a cell-autonomous role in causing early pathological changes to dendritic and synaptic structures of motor neurons, and that these changes precede motor defects and other well-known pathological features of ALS/FTD. Finally, these findings provide further support that modulation of the NF-κB pathway in ALS/FTD is an important therapeutic approach to attenuate disease.

PINK1 and Parkin Are Genetic Modifiers for FUS-induced Neurodegeneration.

Expression of Human FUS Protein in Drosophila Leads to Progressive Neurodegeneration

Mitochondrial Pathology and Muscle and Dopaminergic Neuron Degeneration Caused by Inactivation of Drosophila Pink1 is Rescued by Parkin.

PP2A and GSK3 act as modifiers of FUS-ALS by modulating mitochondrial transport

Distinct multilevel misregulations of Parkin and PINK1 revealed in cell and animal models of TDP-43 proteinopathy

The PINK1/Parkin pathway regulates mitochondrial morphology

Pink1 Defect Causes Mitochondrial Dysfunction, Proteasomal Deficit And Alpha-Synuclein Aggregation In Cell Culture Models Of Parkinson'S Disease

PINK1-mediated phosphorylation of Parkin boosts Parkin activity in Drosophila

Mul1 Acts in Parallel to the Pink1/Parkin Pathway in Regulating Mitofusin and Compensates for Loss of Pink1/Parkin

Mitochondrial dysfunction and NDUFS3: Insights from a PINK1B9 Drosophila model in Parkinson's disease pathogenesis

The Pink-Parkin Circuit in Mitochondrial Quality Control

Neuronal dysfunction caused by FUSR521G promotes ALS-associated phenotypes that are attenuated by NF-κB inhibition

Toxic Gain of Function from Mutant FUS Protein is Crucial to Trigger Cell Autonomous Motor Neuron Loss

Mutant FUS causes DNA ligation defects to inhibit oxidative damage repair in Amyotrophic Lateral Sclerosis

Dysfunction in nonsense-mediated decay, protein homeostasis, mitochondrial function, and brain connectivity in ALS-FUS mice with cognitive deficits

PINK 1 Phosphorylates Drp1 S616 to Regulate Mitophagy‐independent Mitochondrial Dynamics

Mutations in FUS lead to synaptic dysregulation in ALS-iPSC derived neurons

FUS P525L Mutation Causing Amyotrophic Lateral Sclerosis and Movement Disorders.

FUS Interacts with HSP60 to Promote Mitochondrial Damage.

FUS unveiled in mitochondrial DNA repair and targeted ligase-1 expression rescues repair-defects in FUS-linked motor neuron disease

Pink1-Dependent Recruitment of Parkin to Mitochondria in Mitophagy